Dutch Committee Admits Harms of Gender Drugs for Minors but Won't Stop Them

A Dutch committee has acknowledged that giving puberty blockers and cross-sex hormones to trans-identified youth can cause adverse medical and physical effects, yet declined to abandon the practice. The admission is notable because the Netherlands pioneered the pediatric gender-transition model now under scrutiny worldwide. Critics say the committee's decision to double down despite conceding harms exposes a growing gap between mounting evidence and entrenched clinical practice.